Category 3: Tactical Day-to-Day Nutrition & Safety ยท Episode 30

What Actually Happens When You Stop Taking a GLP-1

Clinical Answer Capsule: Abrupt cessation of GLP-1 therapy triggers an acute neuro-endocrine rebound: the STEP-1 trial extension confirmed that patients experience immediate ghrelin hyper-secretion, loss of appetite suppression, and regain two-thirds of lost weight within 12 months. Discontinuation must be structured as a 6-to-12-month deprescribing taper with prioritized protein and resistance training.
STEP-1 Extension TrialGhrelin Hyper-Secretion ReboundIncretin Deprescribing ProtocolSatiety Collapse KineticsLong-Term Metabolic Stabilization
Executive Action Script
"Discontinuing GLP-1 therapy triggers an acute neuro-endocrine rebound: ghrelin spikes while active GLP-1 signaling vanishes. Tapering must be managed medically over 6-12 months."

Full Video Dialogue & Clinical Context

Wondering what actually happens when you stop taking your GLP-1? Clinical trials don't lie: within weeks of stopping, hunger hormones like ghrelin roar back with a vengeance, satiety signals collapse, and two-thirds of the lost weight comes back within a year. That isn't because you failed; it's because incretin deficiency is a chronic condition, just like high blood pressure. If you must taper, do it slowly over months with heavy protein and resistance training. Learn the science in FAT BITCH at fatbitchbook.com and bitchesandbesties.com/armory.

๐Ÿ”ฌ Verified Clinical Reference:
Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab 2022; 24(8):1553-1564. PMID: 35482346
Access Study: https://pubmed.ncbi.nlm.nih.gov/35482346/
Featured Armory Instrument
FAT BITCH: Killing the Willpower Myth (Book & Manifesto)
The definitive cultural and scientific guide to dismantling the willpower myth and establishing permanent body sovereignty.
Unlock Free Instrument in The Armory โ†’